Fujifilm Biotechnologies Opens Advanced QC Lab in Denmark

FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, held a ribbon‑cutting ceremony to mark the opening of its new, 2,000‑square‑meter² quality control (QC) laboratory at its Hillerød, Denmark, commercial‑scale manufacturing site. The expanded QC footprint will enable bioassay and virology operations to meet current and future customer demand and support the site’s planned expansion.

Designed for flexibility and future growth, the laboratory features modern ventilation systems, personnel and material airlocks, and an open‑plan layout. The space supports approximately 100 quality team members to conduct viral safety testing for drug substance/product release, scale capacity for complex cell‑based potency and ELISA methods, and perform raw material and critical total organic carbon cleanability studies to accelerate future partner campaigns. The QC laboratory also incorporates robotics and an ongoing LIMS implementation across the company’s global network of sites to enable digital harmonization and data integrity.

The ribbon‑cutting ceremony was attended by FUJIFILM Biotechnologies leadership and employees, as well as Mikio Mori, Ambassador of Japan to Denmark, Hillerød Municipality Mayor Christoffer Lorenzen, and Thomas Senderovitz, M.D., The Danish Association of the Pharmaceutical Industry (Lif).